Citadel Advisors’s T-Rex 2X Inverse MSTR Daily Target ETF MSTZ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-13,364
Closed -$179K 14541
2025
Q4
$229K Sell
13,364
-285,372
-96% -$2.9M ﹤0.01% 10737
2025
Q3
$1.57M Buy
298,736
+111,214
+59% +$499K ﹤0.01% 6568
2025
Q2
$784K Sell
187,522
-124,972
-40% -$784K ﹤0.01% 7610
2025
Q1
$4.38M Buy
+312,494
New +$5.48M ﹤0.01% 4098

Other funds holding MSTZ

Citadel Advisors's MSTZ Position: Q1 2026 in Review

Citadel Advisors sold out of T-Rex 2X Inverse MSTR Daily Target ETF (MSTZ) in Q1 2026, closing a stake of 13,364 shares — an estimated $179K sold.

Citadel Advisors first reported a position in MSTZ in Q1 2025 and held it in 4 quarters. The position peaked at $4.38M in Q1 2025. 16 funds tracked by Wall St. Rank hold MSTZ as of Q1 2026.

  • Citadel Advisors reported no remaining T-Rex 2X Inverse MSTR Daily Target ETF position as of Q1 2026 after selling out during the quarter.
  • Citadel Advisors sold 13,364 T-Rex 2X Inverse MSTR Daily Target ETF shares in Q1 2026, an estimated $179K.
  • Citadel Advisors first reported a position in T-Rex 2X Inverse MSTR Daily Target ETF in Q1 2025 and held it in 4 quarters.
  • Citadel Advisors's T-Rex 2X Inverse MSTR Daily Target ETF position peaked at $4.38M in Q1 2025.
  • 16 funds tracked by Wall St. Rank held T-Rex 2X Inverse MSTR Daily Target ETF as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.